CXCL1 and neoplasm: In line with this, our results showed that the PAR1 inhibitor suppressed TNF-α and CXCL1 production and rKLK6-promoted tumor growth and metastasis in the xenograft model, suggesting that PAR1 plays a critical role in KLK6-mediated malignant progression.